315 related articles for article (PubMed ID: 27469981)
1. Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic.
Tanaka SK; Steenbergen J; Villano S
Bioorg Med Chem; 2016 Dec; 24(24):6409-6419. PubMed ID: 27469981
[TBL] [Abstract][Full Text] [Related]
2. Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent.
Zhanel GG; Esquivel J; Zelenitsky S; Lawrence CK; Adam HJ; Golden A; Hink R; Berry L; Schweizer F; Zhanel MA; Bay D; Lagacé-Wiens PRS; Walkty AJ; Lynch JP; Karlowsky JA
Drugs; 2020 Feb; 80(3):285-313. PubMed ID: 31970713
[TBL] [Abstract][Full Text] [Related]
3. Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infections.
Villano S; Steenbergen J; Loh E
Future Microbiol; 2016 Oct; 11():1421-1434. PubMed ID: 27539442
[TBL] [Abstract][Full Text] [Related]
4. Omadacycline: A Novel Tetracycline Derivative With Oral and Intravenous Formulations.
Watkins RR; Deresinski S
Clin Infect Dis; 2019 Aug; 69(5):890-896. PubMed ID: 30893428
[TBL] [Abstract][Full Text] [Related]
5. Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe: Results from the SENTRY Antimicrobial Surveillance Programme, 2017.
Huband MD; Pfaller MA; Shortridge D; Flamm RK
J Glob Antimicrob Resist; 2019 Dec; 19():56-63. PubMed ID: 30825698
[TBL] [Abstract][Full Text] [Related]
6. Return of the tetracyclines: omadacycline, a novel aminomethylcycline antimicrobial.
Cho JC; Childs-Kean LM; Zmarlicka MT; Crotty MP
Drugs Today (Barc); 2018 Mar; 54(3):209-217. PubMed ID: 29771255
[TBL] [Abstract][Full Text] [Related]
7. Omadacycline: A New Tetracycline Antibiotic.
Dougherty JA; Sucher AJ; Chahine EB; Shihadeh KC
Ann Pharmacother; 2019 May; 53(5):486-500. PubMed ID: 30917674
[TBL] [Abstract][Full Text] [Related]
8. Omadacycline: a therapeutic review of use in community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.
Chopra T; Sandhu A; Theriault N; Meehan J; Tillotson G
Future Microbiol; 2020 Sep; 15():1319-1333. PubMed ID: 32959689
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline.
Macone AB; Caruso BK; Leahy RG; Donatelli J; Weir S; Draper MP; Tanaka SK; Levy SB
Antimicrob Agents Chemother; 2014; 58(2):1127-35. PubMed ID: 24295985
[TBL] [Abstract][Full Text] [Related]
10. Omadacycline: A Modernized Tetracycline.
Gallagher JC
Clin Infect Dis; 2019 Aug; 69(Suppl 1):S1-S5. PubMed ID: 31367739
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of the novel aminomethylcycline antibiotic omadacycline.
Draper MP; Weir S; Macone A; Donatelli J; Trieber CA; Tanaka SK; Levy SB
Antimicrob Agents Chemother; 2014; 58(3):1279-83. PubMed ID: 24041885
[TBL] [Abstract][Full Text] [Related]
12. Omadacycline Enters the Ring: A New Antimicrobial Contender.
Barber KE; Bell AM; Wingler MJB; Wagner JL; Stover KR
Pharmacotherapy; 2018 Dec; 38(12):1194-1204. PubMed ID: 30290000
[TBL] [Abstract][Full Text] [Related]
13. A Review of Omadacycline for Potential Utility in the Military Health System for the Treatment of Wound Infections.
Zurawski DV; Serio AW; Black C; Pybus B; Akers KS; Deck DH; Johnson S; Chattagul S; Noble SM; Raynor M; Lanteri CA
Mil Med; 2024 May; 189(5-6):e1353-e1361. PubMed ID: 37963013
[TBL] [Abstract][Full Text] [Related]
14. Omadacycline: A Review of the Clinical Pharmacokinetics and Pharmacodynamics.
Rodvold KA; Burgos RM; Tan X; Pai MP
Clin Pharmacokinet; 2020 Apr; 59(4):409-425. PubMed ID: 31773505
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and Safety of Omadacycline in Subjects with Impaired Renal Function.
Berg JK; Tzanis E; Garrity-Ryan L; Bai S; Chitra S; Manley A; Villano S
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158281
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationship of the aminomethylcyclines and the discovery of omadacycline.
Honeyman L; Ismail M; Nelson ML; Bhatia B; Bowser TE; Chen J; Mechiche R; Ohemeng K; Verma AK; Cannon EP; Macone A; Tanaka SK; Levy S
Antimicrob Agents Chemother; 2015 Nov; 59(11):7044-53. PubMed ID: 26349824
[TBL] [Abstract][Full Text] [Related]
17. Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial.
O'Riordan W; Cardenas C; Shin E; Sirbu A; Garrity-Ryan L; Das AF; Eckburg PB; Manley A; Steenbergen JN; Tzanis E; McGovern PC; Loh E;
Lancet Infect Dis; 2019 Oct; 19(10):1080-1090. PubMed ID: 31474458
[TBL] [Abstract][Full Text] [Related]
18. Microbiology and Preclinical Review of Omadacycline.
Karlowsky JA; Steenbergen J; Zhanel GG
Clin Infect Dis; 2019 Aug; 69(Suppl 1):S6-S15. PubMed ID: 31367743
[TBL] [Abstract][Full Text] [Related]
19. Safety and Pharmacokinetics of the Aminomethylcycline Antibiotic Omadacycline Administered to Healthy Subjects in Oral Multiple-Dose Regimens.
Bundrant LA; Tzanis E; Garrity-Ryan L; Bai S; Chitra S; Manley A; Villano S
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29180524
[TBL] [Abstract][Full Text] [Related]
20. Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects.
Sun H; Ting L; Machineni S; Praestgaard J; Kuemmell A; Stein DS; Sunkara G; Kovacs SJ; Villano S; Tanaka SK
Antimicrob Agents Chemother; 2016 Dec; 60(12):7431-7435. PubMed ID: 27736760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]